Tag: medication

FRANKLIN LAKES, N.J., Aug. 4, 2025 /PRNewswire/ -- BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today announced plans to...

In a year defined by holistic health trends, anti-inflammatory nutrition stacks, and consumer-led demand for clean-label routines, Pilly Labs is emerging as a go-to gummy supplement brand for wellness seekers prioritizing transparency and convenience. With turmeric, mushroom extracts, and collagen continuing to dominate 2025’s ingredient interest charts, Pilly Labs’ natural formulations are gaining traction across TikTok rituals, Google search trends, and Reddit supplement stacks — not as prescriptions, but as daily wellness additions for those exploring inflammation support and whole body vitality.

In a year defined by holistic health trends, anti-inflammatory nutrition stacks, and consumer-led demand for clean-label routines, Pilly Labs is emerging as a go-to gummy supplement brand for wellness seekers prioritizing transparency and convenience. With turmeric, mushroom extracts, and collagen continuing to dominate 2025’s ingredient interest charts, Pilly Labs’ natural formulations are gaining traction across TikTok rituals, Google search trends, and Reddit supplement stacks — not as prescriptions, but as daily wellness additions for those exploring inflammation support and whole body vitality.

New 5-Minute Routine May Help Naturally Support Knee Cartilage Health, Flexibility, and Joint Comfort at Any Age

New 5-Minute Routine May Help Naturally Support Knee Cartilage Health, Flexibility, and Joint Comfort at Any Age

WASHINGTON, Aug. 1, 2025 /PRNewswire/ -- Today, the National Safety Council issued the following statement in response to the U.S. Senate Appropriations Committee's passage of...

DELRAY BEACH, Fla., Aug. 1, 2025 /PRNewswire/ -- The global Suppositories Market, valued at US$1.56 billion in 2024 stood at US$1.63 billion in 2025 and...

CAMBRIDGE, Mass., July 31, 2025 /PRNewswire/ -- NeuroSense Therapeutics Ltd. (NASDAQ: NRSN) ("NeuroSense"), a late-stage clinical biotechnology company developing novel treatments for severe neurodegenerative diseases, today provided...

Football Fever Grips Hong Kong as nearly 50,000 Fans Pack Kai Tak Download high-resolution images:  HONG KONG, Aug. 1, 2025 /PRNewswire/ -- The Herbalgy Trophy: Arsenal vs...

WILLOW GROVE, Pa., July 31, 2025 /PRNewswire/ -- Pregnant women are at increased risk of illness due to infection compared with other adults, so...

The treatment-resistant hypertension (TRH) market is expected to grow in the coming years due to the rising prevalence of uncontrolled hypertension and associated cardiovascular...

TORONTO, July 31, 2025 /CNW/ - Bayshore HealthCare (Bayshore) is proud to announce its Integrated Care Solutions (ICS) division has achieved Accredited with Commendation...

Cleanfarms announces The Great Twine Round-Up winners (2024-2025)! Congrats to Alberta farmers & 4-H clubs for recycling plastic baler twine!

CONSHOHOCKEN, Pa., July 30, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) (“Madrigal”) today announced that it has entered into an exclusive global license agreement with CSPC Pharmaceutical Group Limited (HKEX Stock CodeL 1093) (“CSPC”) for SYH2086, a preclinical oral small molecule glucagon-like peptide-1 (GLP-1) receptor agonist and orforglipron derivative. Madrigal plans to initiate clinical development in the first half of 2026.

Blue Ribbon LLC features a natural supplement formulated with key nutrients to help support men’s vitality, energy, and healthy testosterone levels.

MOBILE, Ala., July 29, 2025 /PRNewswire/ -- AltaPointe Health is excited to announce the opening of its newest children's outpatient clinic located at 4211...